Assistant Professor, Medicine, Oregon Health and Science University School of Medicine
Internal Medicine
Dr. Jessica R. Castle, MD
|
|
Give Review
Jessica Castle works in the field of Internal Medicine. She studied medicine at Oregon Health & Science University School of Medicine. She over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Jessica R. Castle is also a published MD. She has 20 paper published. The most recent paper is: Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions. She accepts Medicare.
Publications
- Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions.
- Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System.
- Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems.
- A Novel, Stable, Aqueous Glucagon Formulation Using Ferulic Acid as an Excipient.
- Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 Diabetes.
- Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels.
- Biochemical Stabilization of Glucagon at Alkaline pH.
- Can Glucose Be Monitored Accurately at the Site of Subcutaneous Insulin Delivery?
- Mechanisms of glucagon degradation at alkaline pH.
- A review of artificial pancreas technologies With an emphasis on bi-hormonal therapy.
- Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas.
- The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in Type 1 Diabetes.
- Development of a fully automated closed loop artificial pancreas control system With dual pump delivery of insulin and glucagon.
- Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia.
- A controlled study of the effectiveness of an adaptive closed-loop algorithm to minimize corticosteroid-induced stress hyperglycemia in type 1 Diabetes.
- Continuous glucose monitoring in subjects with type 1 Diabetes: improvement in accuracy by correcting for background current.
- Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 Diabetes.
- Amperometric glucose sensors: sources of error and potential benefit of redundancy.
- Factors influencing the effectiveness of glucagon for preventing Hypoglycemia.
Schools
Or Hlth Sci Univ Sch Of Med
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Adrenogenital Disorders
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
Oregon Health & Science University School of Medicine
Drug Facts
| NPI NUMBER | 1346452919 | |
| NPPES Provider LastName | CASTLE | |
| NPPES Provider FirstName | JESSICA | |
| NPPES Provider ZIPCode | 97239 | |
| NPPES Provider State | OR | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 461.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346452919 |
| Last Name Of The Provider | CASTLE |
| First Name Of The Provider | JESSICA |
| View All |
Similar Doctors
|
|
Dr. Todd A. Hochenedel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leah M. Wilson, MD |
|
|
Dr. Narain K. Kumar, MD
This Doctor is OpenDoctor Recommended.
|